Dichlorvos (DDVP) Risk Characterization Document - California ...

Dichlorvos (DDVP) Risk Characterization Document - California ... Dichlorvos (DDVP) Risk Characterization Document - California ...

30.12.2013 Views

Potency values were estimated by fitting the Global 86 model to the incidences of pancreatic adenoma, mononuclear leukemia, and forestomach papilloma or carcinoma identified in the NTP study (Chan, 1989) and are listed in Table 15 (Appendix E). The potency values estimated from experimental animals were extrapolated to humans assuming the interspecies dose equivalence based on the body weight to the 3/4 power (see Equation 4 in Appendix D). Using this assumption, a factor of 1/4 power of the human-to-animal body weight ratio was applied. In this document, the theoretical cancer risk associated with the use of DDVP was assessed based on the incidence of mononuclear cell leukemias found in rats (Chan, 1989). This endpoint was chosen because it was a systemic effect and the result was statistically significant for both the Trend Test and the Fisher's Exact Test. The finding of pancreatic adenoma was not used because of the possible influence of corn oil in the induction and the lack of evidence for malignancy. The finding of forestomach tumors in mice was also not used in this assessment because the human equivalent potency factor was 5-fold lower than that for mononuclear cell leukemias in the rat. While there is no direct counterpart to the rodent forestomach, the human esophagus and possibly the squamous epithelium at the squamocolumnar junction of the cardiac portion of the stomach may be a site for either squamous cell carcinoma or adenocarcinoma (Huff, 1992). Table 15. The maximum likelihood estimates and 95% upper confidence limit for tumors in rodents treated with DDVP a . Maximum Tumor type likelihood estimate (q 1 ) 95% upper confidence limit (q 1 *) animal human b animal human b Pancreatic adenoma 0.097 0.33 0.15 0.52 mg/kg-day -1 Mononuclear leukemia 0.058 0.20 0.10 0.35 mg/kg-day -1 Forestomach papilloma 0.000 0.00 0.011 0.073 mg/kg-day -1 or carcinoma a/ Data were from Chan, 1989. b/ The human equivalent q 1 and q 1 * were calculated by (Appendix D Equation 4 for derivation): q 1 human = q 1 animal x (human body weight/animal body weight) ¼ where the human body weight = 70 kg, rat body weight = 0.5 kg, and mouse body weight = 0.037 kg. For example: for pancreatic adenoma: q 1 human = 0.097 x (70/0.5) ¼ = 0.33 61

B. EXPOSURE ASSESSMENT The exposure of the general population to DDVP is primarily associated with its use in space treatment of agricultural, commercial, and residential buildings. DDVP has limited use on RACs; however, it is used for post-harvest treatment for bulk and packaged commodities, and on livestock. Exposure estimates for various categories of occupational and residential exposures, were based on the information provided by the Worker Health and Safety Branch (Appendix B). There is no seasonal exposure. Occupational Exposure The absorbed daily dosages of DDVP in workers ranged from 9 ug/kg for structural pest control operators (PCOs) to 62 ug/kg for livestock applicators (Table 16). For chronic exposure, the livestock applicators had the highest exposure level at 4.6 ug/kg-day for annual average daily dosage (AADD) and 2.6 ug/kg-day for lifetime average daily dosage (LADD). Residential Exposure Residents were exposed to DDVP in the homes due to direct applications (referred to as structural residents) and from the release of DDVP from indoor foggers, no-pest strips, and flea collars. The absorbed daily dosages ranged from 0.3 ug/kg for pet-owners to 125 ug/kg for children from the use of foggers (Table 16). Children exposed to no-pest strips had the highest chronic exposure levels at 6.6 ug/kg-day for AADD and 3.1 ug/kg-day for LADD. Table 16. Estimated occupational and residential exposures to DDVP a . Absorbed Daily Dosage Exposure AADD b LADD b Exposure type (ug/kg-day) (days/year) (ug/kg-day) (ug/kg-day) Occupational Warehouse worker 12 17 0.6 0.3 Structural PCO 9 30 0.8 0.4 Livestock applicator 62 27 4.6 2.6 Residential Structural (Resident) 10 6 0.2 0.11 Home-use fogger (child) 125 6 2.05 0.88 Home-use fogger (adult) 74 6 1.22 0.70 Pet owner 0.3 60 0.05 0.03 Pest strip (child) 40 60 6.6 3.1 Pest strip (adult) - - - 2.47 c a/ b/ c/ Data were adopted from Appendix B Table 3 (all except fogger exposure) and Table 4 for biological monitoring (fogger exposure). AADD=Annual average daily dosage, and LADD=Lifetime average daily dosage. Adult exposure level was estimated using the ratio of adult/child exposures for home-use fogger: 3.1 x (0.70/0.88) = 2.47 ug/kg-day. This estimate will be used for the calculation of lifetime exposure to pest strips. 62

Potency values were estimated by fitting the Global 86 model to the incidences of pancreatic<br />

adenoma, mononuclear leukemia, and forestomach papilloma or carcinoma identified in the NTP<br />

study (Chan, 1989) and are listed in Table 15 (Appendix E). The potency values estimated from<br />

experimental animals were extrapolated to humans assuming the interspecies dose equivalence<br />

based on the body weight to the 3/4 power (see Equation 4 in Appendix D). Using this assumption, a<br />

factor of 1/4 power of the human-to-animal body weight ratio was applied.<br />

In this document, the theoretical cancer risk associated with the use of <strong>DDVP</strong> was assessed based on<br />

the incidence of mononuclear cell leukemias found in rats (Chan, 1989). This endpoint was chosen<br />

because it was a systemic effect and the result was statistically significant for both the Trend Test and<br />

the Fisher's Exact Test. The finding of pancreatic adenoma was not used because of the possible<br />

influence of corn oil in the induction and the lack of evidence for malignancy. The finding of<br />

forestomach tumors in mice was also not used in this assessment because the human equivalent<br />

potency factor was 5-fold lower than that for mononuclear cell leukemias in the rat. While there is no<br />

direct counterpart to the rodent forestomach, the human esophagus and possibly the squamous<br />

epithelium at the squamocolumnar junction of the cardiac portion of the stomach may be a site for<br />

either squamous cell carcinoma or adenocarcinoma (Huff, 1992).<br />

Table 15.<br />

The maximum likelihood estimates and 95% upper confidence limit for tumors in<br />

rodents treated with <strong>DDVP</strong> a .<br />

Maximum<br />

Tumor type likelihood estimate (q 1 ) 95% upper confidence limit (q 1 *)<br />

animal human b animal human b<br />

Pancreatic adenoma 0.097 0.33 0.15 0.52 mg/kg-day -1<br />

Mononuclear leukemia 0.058 0.20 0.10 0.35 mg/kg-day -1<br />

Forestomach papilloma 0.000 0.00 0.011 0.073 mg/kg-day -1<br />

or carcinoma<br />

a/ Data were from Chan, 1989.<br />

b/ The human equivalent q 1 and q 1 * were calculated by (Appendix D Equation 4 for derivation):<br />

q 1 human = q 1 animal x (human body weight/animal body weight) ¼<br />

where the human body weight = 70 kg, rat body weight = 0.5 kg, and<br />

mouse body weight = 0.037 kg.<br />

For example: for pancreatic adenoma: q 1 human = 0.097 x (70/0.5) ¼ = 0.33<br />

61

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!